Canada: Securities Regulators Referee The Aurora Hostile Bid For CanniMed

Overview

On December 22, 2017, the Ontario Securities Commission (the OSC) and the Financial and Consumer Affairs Authority of Saskatchewan (the FCAAS and, together with the OSC, the Commissions) made an order cease trading the shareholder rights plan adopted by CanniMed Therapeutics Inc. (CanniMed) in response to an unsolicited take-over bid by Aurora Cannabis Inc. (Aurora). The order followed a joint hearing by the Commissions and marks the first "poison pill" decision by Canadian securities regulators under the new take-over bid regime which was adopted across Canada in May 2016 (the New TOB Regime). The order (and more importantly, the detailed reasons that will follow) are of considerable interest to market participants considering the evolving Canadian take-over bid landscape.

Timeline of events

November 14, 2017 - Aurora issued a press release announcing that it had submitted a proposal to the board of directors of CanniMed to acquire all of the issued and outstanding common shares of CanniMed.

November 17, 2017 - CanniMed and Newstrike Resources Ltd. (Newstrike) announced that they had reached a friendly acquisition agreement under which CanniMed would acquire all of the outstanding shares of Newstrike. The proposed transaction would proceed by way of a plan of arrangement pursuant to which Newstrike shareholders would receive CanniMed shares in exchange for their Newstrike shares. Completion of the transaction would be subject to approval by shareholders of both companies.

November 24, 2017 - Aurora announced that it had formally commenced an unsolicited takeover under which it would offer to purchase all of the issued and outstanding common shares of CanniMed conditional on, among other things, the termination of the Newstrike transaction (the Aurora Bid).

November 28, 2017 - CanniMed announced that it adopted a shareholder rights plan (the Rights Plan). The Rights Plan prevented Aurora from acquiring any CanniMed shares other than those tendered to the Aurora Bid or from entering into any lock-up agreements in respect of the Aurora Bid other than those it had already entered into.

December 4, 2017 - Aurora applied to the Commissions to cease trade the CanniMed Rights Plan and to shorten the minimum deposit period for its bid from 105 days to 35 days.

December 11, 2017 - CanniMed applied to the Commissions to prevent Aurora from purchasing an additional 5% of CanniMed's shares; and the special committee of independent directors of CanniMed (the Special Committee) applied to the Commissions for an order that certain shareholders that had entered into "hard" lock-up agreements in respect of the Aurora Bid (the Locked-Up Shareholders) be deemed to be "joint actors" with Aurora.

Issues before the Commissions

1. Should the minimum bid period for the Aurora Bid be reduced from 105 days?

Aurora applied for exemptive relief from the 105-day minimum bid period requirements under the New TOB Regime. If granted, the relief would reduce the minimum bid period to at least 35 days from the date of the bid. The New TOB Regime shortens the 105-day minimum period in circumstances where the target issues a news release announcing that it intends to effect an "alternative transaction" (effectively a friendly change of control transaction that is not a bid, such as an arrangement). While the Newstrike transaction did not meet the technical definition of an "alternative transaction" under the New TOB Regime, Aurora argued that CanniMed's transaction with Newstrike should nevertheless be categorized as an "alternative transaction," thus permitting Aurora to shorten the deposit period of the Aurora Bid to 35 days. The Commissions denied Aurora's application to shorten the minimum bid period from 105 days.

2. Should the Commissions cease trade the Rights Plan?

Prior to the New TOB Regime, Canadian issuers made use of shareholder rights plans to effectively extend the 35-day minimum bid period. Such shareholder rights plans were historically cease traded by securities regulators within 50 to 70 days of the commencement of an offer (although, there were notable variations in certain decisions). Under the New TOB Regime, target issuers are afforded 105 days to respond to an unsolicited bid, a period that is in excess of the amount of time that securities regulators historically provided Canadian issuers before cease trading a rights plan. In extending the minimum bid period to 105 days, the New TOB Regime attempts to create less of an incentive for issuers to adopt tactical shareholder rights plans, other than to prevent "creeping bids" (such as bids made through normal course purchases and/or private agreement exemptions) and to prevent hard lock-up agreements. The expectation at the time the New TOB Regime was implemented was that securities regulators would be less tolerant of tactical rights plans. In cease trading the CanniMed Rights Plan, the Commissions have met this expectation and are signalling that tactical plans will play less of a role under the New TOB Regime.

3. Should Aurora be prohibited from creeping 5%?

A bidder that has launched a take-over bid is generally prohibited from purchasing additional securities that are the subject of a bid. A limited exception to this prohibition allows a bidder to purchase up to 5% of the target's outstanding securities provided certain conditions are met (the 5% Exemption). It was CanniMed's submission that Aurora should not be allowed to benefit from the 5% Exemption because any further purchases by Aurora would, when considered together with shares held by the Locked-Up Shareholders, limit the possibility for a transaction that would give CanniMed's shareholders a better choice than the Aurora Bid. The Commissions were not persuaded and the order did not prohibit Aurora from availing itself of the 5% Exemption.

4. Are Aurora and the Locked-Up Shareholders "joint actors"?

The Special Committee alleged that the Locked-Up Shareholders played an integral role in the planning, promoting and structuring of the Aurora Bid and acted together with Aurora to bring about the Aurora Bid. A determination that a Locked-Up Shareholder is a joint actor with Aurora with respect to the Aurora Bid would have several implications, including: (a) the shares held by the joint actor(s) would be excluded from the 50% minimum tender condition; and (b) the votes attaching to the shares held by the joint actor(s) would be excluded from any minority approval of a subsequent acquisition transaction. In addition, the Aurora Bid would also be deemed an "insider bid" subject to enhanced disclosure requirements and a formal valuation. The Commissions did not disclose in the order their conclusion as to whether or not Aurora and the Locked-Up Shareholders are "joint actors," but did order Aurora to make certain additional disclosure which may shed further light on these relationships.

Concluding remark

As the first poison pill order under the New TOB Regime, this order suggests that the Commissions are signalling that they will have little appetite for tactical rights plans going forward and may be less inclined to involve themselves in unsolicited bids. A further Osler Update will follow upon the release of the reasons by the Commissions.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions